Mersana Therapeutics buy michaelkr
Start price
28.11.21
/
50%
€6.15
Target price
28.11.22
-
Performance (%)
-15.45%
End price
12.12.21
€5.20
Summary
This prediction ended on 12.12.21 with a price of €5.20. The prediction for Mersana Therapeutics disappointed with a performance of -15.45%. michaelkr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Mersana Therapeutics | 4.986% | 4.986% | 13.295% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% |
According to michaelkr what are the pros and cons of Mersana Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by michaelkr for this prediction
In the thread Mersana Therapeutics diskutieren
Buy Mersana Therapeutics
In the thread Trading Mersana Therapeutics
Buy beendet
Stopped prediction by michaelkr for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.12
14.08.24
14.08.24
-
14.08.25
14.08.25
6.38%
18.08.24
18.08.24
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.00
22.06.24
22.06.24
-
22.06.25
22.06.25
-17.76%
02.07.24
02.07.24
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.86
10.12.23
10.12.23
-
10.12.24
10.12.24
7.53%
23.12.23
23.12.23
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.00
27.07.23
27.07.23
-
27.07.24
27.07.24
12.35%
05.08.23
05.08.23
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€3.50
10.07.23
10.07.23
-
10.07.24
10.07.24
-1.86%
22.07.23
22.07.23
Could be very worthwhile Investment >20% year
Mersana Therapeutics
Start price
Target price
Perf. (%)
€8.07
11.06.23
11.06.23
-
11.06.24
11.06.24
-65.32%
23.06.23
23.06.23
Could be very worthwhile Investment >20% year